Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
iBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
iBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
iBio Inc, Medical Devices Deals, 2011 to YTD 2017 10
iBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
iBio Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
iBio Acquires Orphan Drug Designation And Related Property Rights From Kentucky Bioprocessing 13
Partnerships 14
Texas A&M University Enters into Agreement with iBio 14
iBio Amends Agreement with Medical University of South Carolina 15
iBio Amends Co-Development Agreement With Fraunhofer 16
Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 17
iBio Enters into Agreement with Novici Biotech 18
Licensing Agreements 19
iBio Amends Licensing Agreement with US University 19
iBio Enters into Licensing Agreement with Caliber Biotherapeutics 20
iBio Extends Licensing Agreement with Fraunhofer 21
iBio Extends its Licensing Agreement with Bio-Manguinhos 22
iBio Enters into Licensing Agreement with University of Pittsburgh 23
iBio Enters Into Licensing Agreement With Caliber Biotherapeutics 24
iBio Enters Into Licensing Agreement With Bio-Manguinhos 26
Equity Offering 27
iBio to Raise Funds in Public Offering of Shares 27
iBio Raises USD1 Million in First Tranche of Private Placement of Shares 28
iBio Raises USD4 Million in Second and Final Tranche of Private Placement of Shares 30
iBio Raises USD2.2 Million in First Tranche of Private Placement of Shares 31
iBio Raises USD1 Million in Private Placement of Shares up on Exercise of Warrants 32
iBio Plans to Raise up to USD15 Million in Private Placement of Shares 33
iBio Raises USD10 Million in Private Placemet of Shares 34
iBio Raises USD0.5 Million in First Tranche of Private Placement of Shares 35
Ibio Completes Public Offering Of Units For US$4 Million 36
ibio Announces Private Placement Of Shares For Up To US$10 Million 37
iBio, Biotechnology Company, Completes Public Offering Of Common Stock For US$10 Million 38
iBio Inc – Key Competitors 39
iBio Inc – Key Employees 40
iBio Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Legal and Regulatory 42
Nov 06, 2017: iBio Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court 42
Aug 15, 2016: Implications of Court Decision in Favor of iBio Against Fraunhofer 43
Aug 08, 2016: Delaware Chancery Court confirms Fraunhofer USA Rights 45
Aug 04, 2016: iBio’s Claims Against Fraunhofer Affirmed by Delaware Chancery Court 46
Product News 47
Sep 29, 2016: iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies 47
Other Significant Developments 48
Oct 30, 2017: iBio CDMO President to Co-Chair South African Molecular Pharming Conference 48
May 04, 2017: iBio Provides Corporate Update at Annual Shareholders Meeting 49
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
iBio Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
iBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
iBio Inc, Deals By Therapy Area, 2011 to YTD 2017 9
iBio Inc, Medical Devices Deals, 2011 to YTD 2017 10
iBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
iBio Acquires Orphan Drug Designation And Related Property Rights From Kentucky Bioprocessing 13
Texas A&M University Enters into Agreement with iBio 14
iBio Amends Agreement with Medical University of South Carolina 15
iBio Amends Co-Development Agreement With Fraunhofer 16
Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 17
iBio Enters into Agreement with Novici Biotech 18
iBio Amends Licensing Agreement with US University 19
iBio Enters into Licensing Agreement with Caliber Biotherapeutics 20
iBio Extends Licensing Agreement with Fraunhofer 21
iBio Extends its Licensing Agreement with Bio-Manguinhos 22
iBio Enters into Licensing Agreement with University of Pittsburgh 23
iBio Enters Into Licensing Agreement With Caliber Biotherapeutics 24
iBio Enters Into Licensing Agreement With Bio-Manguinhos 26
iBio to Raise Funds in Public Offering of Shares 27
iBio Raises USD1 Million in First Tranche of Private Placement of Shares 28
iBio Raises USD4 Million in Second and Final Tranche of Private Placement of Shares 30
iBio Raises USD2.2 Million in First Tranche of Private Placement of Shares 31
iBio Raises USD1 Million in Private Placement of Shares up on Exercise of Warrants 32
iBio Plans to Raise up to USD15 Million in Private Placement of Shares 33
iBio Raises USD10 Million in Private Placemet of Shares 34
iBio Raises USD0.5 Million in First Tranche of Private Placement of Shares 35
Ibio Completes Public Offering Of Units For US$4 Million 36
ibio Announces Private Placement Of Shares For Up To US$10 Million 37
iBio, Biotechnology Company, Completes Public Offering Of Common Stock For US$10 Million 38
iBio Inc, Key Competitors 39
iBio Inc, Key Employees 40
iBio Inc, Subsidiaries 41